Waters Parkerson & Co., LLC Abb Vie Inc. Transaction History

Waters Parkerson & Co., LLC

$1.97 Billion
Q3 2024

A detailed history of Waters Parkerson & Co., LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 6,891 shares of ABBV stock, worth $1.24 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,891

Previous 6,891 -0.0%

Holding current value

$1.24 Million

Previous $1.18 Million 15.14%

% of portfolio

0.07%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $18,420 - $21,510	-119 Reduced 1.7%	6,891 $1.18 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $4,474 - $5,098	-28 Reduced 0.4%	7,010 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $57,654 - $64,932	419 Added 6.33%	7,038 $1.09 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $35,000 - $40,518	-262 Reduced 3.81%	6,619 $987,000
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $68,689 - $79,106	-475 Reduced 6.46%	6,881 $1.1 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $82,986 - $99,522	600 Added 8.88%	7,356 $1.19 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $27,524 - $34,992	200 Added 3.05%	6,756 $1.04 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $16,893 - $20,960	128 Added 1.99%	6,556 $1.06 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $51,150 - $56,310	-500 Reduced 7.22%	6,428 $696,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $79,443 - $107,257	987 Added 16.61%	6,928 $742,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $3,178 - $3,730	37 Added 0.63%	5,941 $520,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $161,250 - $244,475	2,500 Added 73.44%	5,904 $450,000
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $100,768 - $121,152	-1,600 Reduced 31.97%	3,404 $258,000
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $1,642 - $2,099	-25 Reduced 0.5%	5,004 $364,000
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $142,256 - $158,144	1,600 Added 46.66%	5,029 $476,000
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $34,925 - $44,610	-500 Reduced 12.73%	3,429 $305,000
Q2 2017 Aug 11, 2017	BUY	N/A	3,929	3,929 $285,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.

Account

Waters Parkerson & Co., LLC Abb Vie Inc. Transaction History